BioXcel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Operational Highlights

Go back to BioXcel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Operational Highlights
(NASDAQ: BTAI) Delayed: 1.20 --0 (-0%)
Previous Close $1.20    52 Week High
Open $1.20    52 Week Low
Day High $1.20    P/E N/A 
Day Low $1.20    EPS
Volume 1,964